Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

409
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
409
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

737
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
737
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

148
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
148
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

671
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
671
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

223
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
223
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

224
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
224

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis.

Journal of biosciences and medicines·2026
Same author

Reply to Ishii et al.: Clarifying the association between sedative selection and outcomes in acute respiratory distress syndrome: methodological considerations.

Annals of the American Thoracic Society·2026
Same author

Geographic Variations of Intensive Care Unit Admissions with Substance-Related Diagnoses in the United States.

Journal of intensive care medicine·2025
Same author

Epidemiology of Substance-Related Admissions to ICUs in the United States.

Critical care medicine·2025
Same author

Sedation Practices during Continuous Neuromuscular Blockade for Acute Respiratory Distress Syndrome.

Annals of the American Thoracic Society·2025
Same author

Ethical interventions: revisiting the assessment tools for health-system pharmacists.

Frontiers in medicine·2025
Same journal

High Dose Rate (HDR) Brachytherapy for Mycosis Fungoides of the Wrist.

International journal of clinical medicine·2021
Same journal

Pharmacist and Physician Collaborative Practice Model Improves Vancomycin Dosing in an Intensive Care Unit.

International journal of clinical medicine·2020
Same journal

Macrophage TGF-<i>β</i>1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions.

International journal of clinical medicine·2017
Same journal

Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers.

International journal of clinical medicine·2016
Same journal

The Aging Waistline: Impact of the Geriatric Obesity Epidemic on an Urban Emergency Department: Original Communication.

International journal of clinical medicine·2016
Same journal

Differential Measurements of Oxidatively Modified Proteins in Colorectal Adenopolyps.

International journal of clinical medicine·2015
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.2K

Hepatorenal Syndrome.

Tyree H Kiser1

  • 1Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Aurora, USA.

International Journal of Clinical Medicine
|April 15, 2020
PubMed
Summary
This summary is machine-generated.

Hepatorenal syndrome (HRS) management focuses on reversing underlying mechanisms like portal hypertension. Liver transplantation is definitive, while therapies like terlipressin aim to improve transplant eligibility.

Keywords:
CirrhosisHepatorenal DisorderPortal HypertensionTransplantationVasopressors

More Related Videos

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.1K
Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

2.3K

Related Experiment Videos

Last Updated: Dec 24, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.2K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.1K
Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

2.3K

Area of Science:

  • Hepatology and Nephrology
  • Critical Care Medicine

Background:

  • Hepatorenal syndrome (HRS) is a severe complication of advanced liver disease.
  • It involves complex pathophysiological mechanisms including portal hypertension, splanchnic vasodilation, and renal vasoconstriction.
  • HRS significantly increases morbidity and mortality in patients with liver conditions.

Purpose of the Study:

  • To review current treatment strategies for hepatorenal syndrome.
  • To highlight the role of pharmacologic and non-pharmacologic interventions.
  • To identify areas where further research is needed to improve patient outcomes.

Main Methods:

  • Literature review of existing studies on hepatorenal syndrome treatments.
  • Analysis of pharmacologic therapies including terlipressin, norepinephrine, vasopressin, midodrine, and octreotide.
  • Evaluation of non-pharmacologic interventions such as artificial hepatic support devices, renal replacement therapy, and transjugular intrahepatic portosystemic shunt (TIPS).

Main Results:

  • Liver transplantation remains the preferred definitive treatment for HRS.
  • Terlipressin with albumin is the leading pharmacologic therapy; alternatives exist where terlipressin is unavailable.
  • For Type II HRS, midodrine plus octreotide offers an outpatient treatment option.
  • Non-pharmacologic options like hepatic support devices and renal replacement therapy have not shown improved outcomes; TIPS has limitations in Type I HRS.

Conclusions:

  • Current treatments aim to reverse HRS mechanisms and prolong survival for liver transplantation.
  • Careful monitoring is crucial during vasoconstrictor therapy to prevent adverse effects.
  • Further research is essential to enhance the management and outcomes for patients with hepatorenal syndrome.